4
Changes in Ownership
Sionna Therapeutics, Inc. Filed Acc 0001704336-26-000005
President & CEO acquired 218,050 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Cloonan Michael · President & CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-09-17 | Grant or award : show line 1 in the form | +109,025 | 656,368 | D |
| 2026-09-17 | Grant or award : show line 2 in the form | +109,025 | 765,393 | D |
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-09-17 | Grant or award : show line 3 in the form Non-Qualified Stock Option (right to buy) | +436,100 | 436,100 | D |
| 2026-09-17 | Returned to the company : show line 4 in the form Non-Qualified Stock Option (right to buy) | −436,100 | 0 | D |
Loading xslF345X06/edgardoc.xml…